In focus · trending topic

skin disorder

2 stories · following the connections

Galectin’s GR-MD-02 Demonstrates Efficacy in Patients with Moderate to Severe Plaque Psoriasis

By Nasdaq OMXMar 6, 2017, 1:31 PM UTC

Galectin’s GR-MD-02 Demonstrates Efficacy in Patients with Moderate to Severe Plaque Psoriasis

By Nasdaq OMXMar 6, 2017, 1:31 PM UTC